Endothelial dysfunction in neurodegenerative disease: Is endothelial inflammation an overlooked druggable target?

Ritson, Megan; Wheeler-Jones, Caroline P.D.; Stolp, Helen B.

doi:10.1016/j.jneuroim.2024.578363

All Outputs (2)

Equine endothelial cells show pro-angiogenic behaviours in response to FGF2 but not VEGF-A. (2024)
Journal Article
Finding, E., Wheeler-Jones, C., Faulkner, A., & Lilly, N. (in press). Equine endothelial cells show pro-angiogenic behaviours in response to FGF2 but not VEGF-A. International Journal of Molecular Sciences, https://doi.org/10.3390/ijms25116017

Endothelial dysfunction in neurodegenerative disease: Is endothelial inflammation an overlooked druggable target? (2024)
Journal Article
Ritson, M., Wheeler-Jones, C. P., & Stolp, H. B. (2024). Endothelial dysfunction in neurodegenerative disease: Is endothelial inflammation an overlooked druggable target?. Journal of Neuroimmunology, 391, 578363. https://doi.org/10.1016/j.jneuroim.2024.578363

Neurological diseases with a neurodegenerative component have been associated with alterations in the cerebrovasculature. At the anatomical level, these are centred around changes in cerebral blood flow and vessel organisation. At the molecular level... Read More about Endothelial dysfunction in neurodegenerative disease: Is endothelial inflammation an overlooked druggable target?.